Gurugram, 30th August 2025: Medanta – The Medicity, ranked India’s Best Private Hospital by Newsweek for six consecutive years, today honoured Dr. Ashok Rajgopal, Group Chairman – Medanta Institute of Musculoskeletal Disorders and Orthopaedics, for completing 40,000 knee replacement surgeries, a milestone achievement that reinforces Medanta’s unparalleled clinical expertise in orthopaedic care.

This landmark feat is a testament to Dr. Rajgopal’s pioneering skills and decades-long experience, as well as Medanta’s commitment to advancing joint replacement care in India by using advanced infrastructure, state-of-the-art technology, and a skilled team of doctors, at an accessible cost.

Dr. Naresh Trehan, Chairman and Managing Director, Medanta, congratulated Dr. Rajgopal and his team for his watershed achievement, and hailed his unwavering dedication to patient care and pioneering work in knee replacement surgery. Mr Pankaj Sahni, Group CEO, Medanta, also lauded Dr Rajgopal’s work, affirming that his expertise, dedication and compassion have set a standard for other doctors to aspire to.

In addition, several of Dr Rajgopal’s patients were present at Medanta – The Medicity to applaud their surgeon, and many shared their respective journeys – from one of pain and vulnerability, to a life of liberty and empowerment, free from any discomfort.

India is facing a growing crisis of joint health, with knee problems emerging as one of the most significant contributors to disability and reduced quality of life. Among these, knee osteoarthritis (OA) is the most common, with nearly 60 million Indians projected to be affected by 2025. Factors such as age-related cartilage degeneration, obesity, sedentary lifestyles, and untreated injuries are driving this rise, leaving many unable to carry out basic daily activities. As a result, knee replacement surgery has become a key treatment, offering pain relief, restored mobility, and improved independence for patients suffering from severe osteoarthritis, rheumatoid arthritis, traumatic knee injuries, and congenital or acquired deformities. This growing demand is reflected in the expanding knee replacement market in India, projected to increase at a steady CAGR of 11% from 2025–2035.

Highlighting his views on the evolving orthopaedics space, Dr. Ashok Rajgopal, Group Chairman, Medanta Institute of Musculoskeletal Disorders and Orthopaedics, Medanta- The Medicity, Gurugram said, "Orthopaedic care in India, particularly knee replacement, has advanced tremendously over the past few years. Today, more than 2.5 lakh knee replacements are performed annually — nearly 2.5 times more than just five years ago.  This sharp rise is being driven by increased longevity, greater awareness, the aspiration to stay active, and the availability of advanced expertise and infrastructure. With advanced surgical techniques and patient-specific approaches, we are able to restore mobility, independence, and quality of life for thousands. At the same time, challenges such as revision surgeries and complications demand careful evaluation and long-term patient care. In our unit, we are equipped to manage even the most complex cases with cutting-edge technology and clinical expertise."

Dr Rajgopal further said, “We treat thousands of patients with advanced knee conditions every year and perform approximately 1600-1700 knee replacements annually, achieving a 98% success rate. We have successfully managed more than 9500 revision surgeries and performed over 1500 robotic-assisted knee replacements. Our focus goes beyond surgical excellence—we emphasize pre-operative assessment, patient education, and structured rehabilitation, which are key to long-term success. With innovations like robotics, minimally invasive techniques, and advanced implants, we are able to personalize treatment, reduce recovery time, and deliver superior outcomes. We remain committed to improving lives through a blend of expertise, compassion, and comprehensive care.”

Hailing Dr. Rajgopal’s achievement, Dr. Naresh Trehan, Chairman and Managing Director, Medanta said, "Dr. Rajgopal’s unwavering dedication to patient care and pioneering work in knee replacement surgery have transformed the lives of thousands. His achievements embody Medanta’s philosophy of making world-class healthcare accessible and affordable. At Medanta, we take pride in bringing together doctors with exemplary expertise and experience, enabling us to deliver the highest standards of care. We will continue to lead the way in adopting advanced technologies and personalized approaches to ensure the best possible outcomes for every patient."

About Global Health Limited (Medanta):

Founded by Dr. Naresh Trehan, a world-renowned cardiovascular and cardiothoracic surgeon who has been awarded the prestigious Padma Bhushan and the Padma Shri, the third- and fourth-highest civilian awards in India, and the Dr. B.C. Roy Award in recognition of his distinguished contribution to medicine.

Global Health Limited (the “Company”) is one of the largest private multi-specialty tertiary care providers operating in the North and East regions of India, with key specialties cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology, according to the report titled “An assessment of the healthcare delivery market in India, September 2022” by CRISIL Limited.

Under the “Medanta” brand, the Company has a network of five hospitals currently in operation (Gurgaon, Indore, Ranchi, Lucknow, and Patna). Spanning an area of 4.7 million sq. ft., its operational hospitals have 3,062 installed beds as on June 30, 2025. It also has one hospital under-construction in Noida and four upcoming hospitals in Mumbai, New Delhi (Pitampura), South Delhi (GK) and Guwahati. The Company provides healthcare services in over 30 medical specialties and engages over 2,000 + doctors led by highly experienced department heads.